Biolife Solutions (BLFS) Current Leases (2019 - 2026)
Biolife Solutions (BLFS) posted quarterly Current Leases of $2.3 million for Q1 2026, up 26.21% year-over-year from $1.8 million in Q1 2025, and up 3.25% quarter-over-quarter from $2.2 million in Q4 2025.
Biolife Solutions (BLFS) Current Leases (2019 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Current Leases for 8 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 26.21% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 26.21% YoY), while the FY2025 annual figure was $2.2 million, up 53.74% from the prior year.
- Current Leases advanced to $2.3 million in Q1 2026 per BLFS's latest filing, from $2.2 million in the prior quarter.
- Across five years, Current Leases topped out at $2.9 million in Q4 2022 and bottomed at $151000.0 in Q1 2022.
- Historically, Current Leases has averaged $1.5 million across 5 years, with a median of $1.8 million in 2025.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 94.11% — and 2024, when it surged 1542.86%.
- Biolife Solutions' Current Leases stood at $2.9 million in 2022, then tumbled by 55.03% to $1.3 million in 2023, then increased by 13.45% to $1.5 million in 2024, then jumped by 53.74% to $2.2 million in 2025, then advanced by 3.25% to $2.3 million in 2026.
- Business Quant data shows BLFS's Current Leases at $2.3 million in Q1 2026, $2.2 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.51 Bn | 129.29 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.45 Bn | 51.59 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.72 Bn | 34.37 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.73 Bn | 32.26 Bn | 861.22 Mn | 29.14 Mn |
| 5 | Medline | 29.08 Bn | 26.41 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.98 Bn | 24.54 Bn | 329.20 Mn | 20.90 Mn |
| 7 | Solventum | 15.38 Bn | 14.98 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.80 Bn | 14.66 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.81 Bn | 1.73 Bn | 18.29 Mn | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.32 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 323,000.00 |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.65 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 398,000.00 |
| Jun 30, 2023 | 426,000.00 |
| Mar 31, 2023 | 161,000.00 |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 156,000.00 |
| Jun 30, 2022 | 2.73 Mn |
| Mar 31, 2022 | 151,000.00 |
| Dec 31, 2021 | 2.76 Mn |
| Sep 30, 2021 | 2.65 Mn |